Stevens Capital Management LP acquired a new stake in Corteva, Inc. (NYSE:CTVA – Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 9,811 shares of the company’s stock, valued at approximately $664,000.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Activest Wealth Management raised its holdings in shares of Corteva by 118.3% in the 3rd quarter. Activest Wealth Management now owns 369 shares of the company’s stock valued at $25,000 after purchasing an additional 200 shares during the period. True Wealth Design LLC grew its holdings in Corteva by 209.5% in the 3rd quarter. True Wealth Design LLC now owns 390 shares of the company’s stock valued at $26,000 after buying an additional 264 shares in the last quarter. Total Investment Management Inc. acquired a new position in shares of Corteva in the second quarter valued at about $27,000. Curat Global LLC boosted its stake in shares of Corteva by 93.7% in the second quarter. Curat Global LLC now owns 370 shares of the company’s stock valued at $28,000 after buying an additional 179 shares during the period. Finally, Twin Peaks Wealth Advisors LLC bought a new position in Corteva during the 2nd quarter worth $29,000. 81.54% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
Several equities analysts have recently commented on the stock. Oppenheimer set a $86.00 target price on shares of Corteva in a research report on Thursday, February 5th. JPMorgan Chase & Co. cut shares of Corteva from an “overweight” rating to a “neutral” rating and increased their target price for the stock from $75.00 to $77.00 in a report on Thursday, February 5th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Corteva in a report on Monday, December 29th. Citigroup increased their price objective on shares of Corteva from $74.00 to $80.00 and gave the company a “neutral” rating in a research note on Thursday, February 5th. Finally, Mizuho boosted their target price on shares of Corteva from $80.00 to $82.00 and gave the stock an “outperform” rating in a research note on Tuesday, February 17th. Two research analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and seven have issued a Hold rating to the company. According to MarketBeat.com, Corteva has an average rating of “Moderate Buy” and a consensus target price of $82.30.
Corteva Trading Down 1.1%
Shares of NYSE CTVA opened at $76.20 on Friday. The firm has a 50 day moving average price of $70.71 and a two-hundred day moving average price of $68.58. The stock has a market cap of $51.25 billion, a P/E ratio of 48.23, a price-to-earnings-growth ratio of 2.60 and a beta of 0.75. Corteva, Inc. has a 52-week low of $53.40 and a 52-week high of $77.41. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.96 and a current ratio of 1.43.
Corteva (NYSE:CTVA – Get Free Report) last posted its quarterly earnings data on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.22. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The business had revenue of $3.91 billion during the quarter, compared to the consensus estimate of $4.23 billion. During the same period in the prior year, the business posted $0.32 earnings per share. Corteva’s quarterly revenue was down 1.7% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, equities analysts forecast that Corteva, Inc. will post 2.96 EPS for the current year.
Corteva Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Monday, March 16th. Shareholders of record on Monday, March 2nd will be given a dividend of $0.18 per share. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. Corteva’s dividend payout ratio is 45.57%.
Corteva Profile
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
Further Reading
- Five stocks we like better than Corteva
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- America’s 1776 happening again
- How a Family Trust May Be Able To Help Preserve Your Wealth
- This makes me furious
- Elon Musk: This Could Turn $100 into $100,000
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
